Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: ACS Appl Mater Interfaces. 2016 Dec 2;8(49):33412–33422. doi: 10.1021/acsami.6b08153

Figure 1.

Figure 1

Synthesis and characterization of PEGylated-PLGA-NPs: (a) Formulation of gemcitabine and antisense-miRNA-21 co-encapsulated PEGylated-PLGA-NPs; (b) hydrodynamic particle size of NPs prepared by w/o/w double emulsion method by dynamic light scattering (DLS); (c) TEM images of PEGylated-PLGA-NPs.